Concert Pharmaceuticals prices 10M stock offering

Jun. 02, 2022 6:13 AM ETConcert Pharmaceuticals, Inc. (CNCE)By: Khyathi Dalal, SA News Editor
  • Concert Pharmaceuticals (NASDAQ:CNCE) priced its underwritten public offering of 10M shares at a public offering price of $4.75/share
  • Gross proceeds are expected to be ~$47.5M.
  • Underwriters granted 30-day option to purchase up to an additional 1.5M shares.
  • Offering is expected to close

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.